These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 37769125)

  • 1. Accounting for Competing Events When Evaluating Long-Term Outcomes in Survivors of Critical Illness.
    Angriman F; Ferreyro BL; Harhay MO; Wunsch H; Rosella LC; Scales DC
    Am J Respir Crit Care Med; 2023 Dec; 208(11):1158-1165. PubMed ID: 37769125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of the Cox model to the Fine-Gray model for survival analyses of re-fracture rates.
    Nolan EK; Chen HY
    Arch Osteoporos; 2020 Jun; 15(1):86. PubMed ID: 32519193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statistical Methods for Cohort Studies of CKD: Survival Analysis in the Setting of Competing Risks.
    Hsu JY; Roy JA; Xie D; Yang W; Shou H; Anderson AH; Landis JR; Jepson C; Wolf M; Isakova T; Rahman M; Feldman HI;
    Clin J Am Soc Nephrol; 2017 Jul; 12(7):1181-1189. PubMed ID: 28242844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performing Survival Analyses in the Presence of Competing Risks: A Clinical Example in Older Breast Cancer Patients.
    de Glas NA; Kiderlen M; Vandenbroucke JP; de Craen AJ; Portielje JE; van de Velde CJ; Liefers GJ; Bastiaannet E; Le Cessie S
    J Natl Cancer Inst; 2016 May; 108(5):. PubMed ID: 26614095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Competing risk analysis in a large cardiovascular clinical trial: An APEX substudy.
    Arbetter DF; Jain P; Yee MK; Michalak N; Hernandez AF; Hull RD; Goldhaber SZ; Harrington RA; Gold A; Cohen AT; Gibson CM
    Pharm Stat; 2017 Nov; 16(6):445-450. PubMed ID: 28840662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing risk factors of non-fatal outcomes amid a competing risk of mortality: the example of hip fracture.
    Buzkova P; Barzilay JI; Mukamal KJ
    Osteoporos Int; 2019 Oct; 30(10):2073-2078. PubMed ID: 31256203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suicide and self-harm in adult survivors of critical illness: population based cohort study.
    Fernando SM; Qureshi D; Sood MM; Pugliese M; Talarico R; Myran DT; Herridge MS; Needham DM; Rochwerg B; Cook DJ; Wunsch H; Fowler RA; Scales DC; Bienvenu OJ; Rowan KM; Kisilewicz M; Thompson LH; Tanuseputro P; Kyeremanteng K
    BMJ; 2021 May; 373():n973. PubMed ID: 33952509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A new perspective of survival data on clinical epidemiology: introduction of competitive risk model].
    Nie ZQ; Ou YQ; Qu YJ; Yuan HY; Liu XQ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Aug; 38(8):1127-1131. PubMed ID: 28847068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What Is the Effect of Using a Competing-risks Estimator when Predicting Survivorship After Joint Arthroplasty: A Comparison of Approaches to Survivorship Estimation in a Large Registry.
    Cuthbert AR; Graves SE; Giles LC; Glonek G; Pratt N
    Clin Orthop Relat Res; 2021 Feb; 479(2):392-403. PubMed ID: 33105301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Introduction to the Analysis of Survival Data in the Presence of Competing Risks.
    Austin PC; Lee DS; Fine JP
    Circulation; 2016 Feb; 133(6):601-9. PubMed ID: 26858290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of pathogen-specific clinical mastitis in the first 100 days of first lactation with productive lifetime: An observational study comparing competing risks models for death and sale with the Cox model.
    Hertl JA; Schukken YH; Tauer LW; Welcome FL; Gröhn YT
    Prev Vet Med; 2023 Apr; 213():105879. PubMed ID: 36841041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ignoring competing events in the analysis of survival data may lead to biased results: a nonmathematical illustration of competing risk analysis.
    Schuster NA; Hoogendijk EO; Kok AAL; Twisk JWR; Heymans MW
    J Clin Epidemiol; 2020 Jun; 122():42-48. PubMed ID: 32165133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Practical recommendations for reporting Fine-Gray model analyses for competing risk data.
    Austin PC; Fine JP
    Stat Med; 2017 Nov; 36(27):4391-4400. PubMed ID: 28913837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different survival analysis methods for measuring long-term outcomes of Indigenous and non-Indigenous Australian cancer patients in the presence and absence of competing risks.
    He VY; Condon JR; Baade PD; Zhang X; Zhao Y
    Popul Health Metr; 2017 Jan; 15(1):1. PubMed ID: 28095862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of delayed graft function on graft and patient survival in kidney transplantation: an approach using competing events analysis.
    Fonseca I; Teixeira L; Malheiro J; Martins LS; Dias L; Castro Henriques A; Mendonça D
    Transpl Int; 2015 Jun; 28(6):738-50. PubMed ID: 25689397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Competing risk of death: an important consideration in studies of older adults.
    Berry SD; Ngo L; Samelson EJ; Kiel DP
    J Am Geriatr Soc; 2010 Apr; 58(4):783-7. PubMed ID: 20345862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. causalCmprsk: An R package for nonparametric and Cox-based estimation of average treatment effects in competing risks data.
    Vakulenko-Lagun B; Magdamo C; Charpignon ML; Zheng B; Albers MW; Das S
    Comput Methods Programs Biomed; 2023 Dec; 242():107819. PubMed ID: 37774426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long term mortality in critically ill burn survivors.
    Nitzschke S; Offodile AC; Cauley RP; Frankel JE; Beam A; Elias KM; Gibbons FK; Salim A; Christopher KB
    Burns; 2017 Sep; 43(6):1155-1162. PubMed ID: 28606748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Competing time-to-event endpoints in cardiology trials: a simulation study to illustrate the importance of an adequate statistical analysis.
    Rauch G; Kieser M; Ulrich S; Doherty P; Rauch B; Schneider S; Riemer T; Senges J
    Eur J Prev Cardiol; 2014 Jan; 21(1):74-80. PubMed ID: 22964966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of competing risks analysis improved prognostic assessment of patients with decompensated chronic heart failure and reduced left ventricular ejection fraction.
    Scrutinio D; Guida P; Passantino A; Ammirati E; Oliva F; Lagioia R; Frigerio M
    J Clin Epidemiol; 2018 Nov; 103():31-39. PubMed ID: 30009940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.